4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Taiko Pharmaceutical Co.,Ltd. (4574) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Osaka, Japan with about 220 employees. Its market capitalization is roughly JPY 13 billion. In the fiscal year ended 2025-12-31, 4574 reported JPY 6.4B in revenue and JPY 923M in net income.
Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines and quasi drugs in Japan and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | JPY 6.4B | JPY 6.3B | JPY 6.1B | JPY 5.0B |
| Gross Profit | JPY 3.5B | JPY 3.7B | JPY 2.6B | JPY 1.1B |
| Operating Income (EBIT) | JPY 459M | JPY 630M | (JPY 1.0B) | (JPY 3.1B) |
| Net Income | JPY 923M | JPY 898M | (JPY 3.6B) | (JPY 4.9B) |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | (JPY 1M) | (JPY 1M) | — | (JPY 782M) |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | JPY 12.3B | JPY 12.9B | JPY 13.2B | JPY 15.0B | — |
| Total Liabilities | JPY 3.8B | JPY 5.0B | JPY 6.5B | JPY 7.0B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4574 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms